Navigation Links
New Vaccine to Bring Dramatic Decrease in Cervical Cancer Deaths

GlaxoSmithKline has reported that its experimental vaccine against a virus that causes cervical cancer could bring about a decrease in the number// of cases and deaths from the illness by up to 76 percent.

Their vaccine, Cervarix prevents the infection from two strains of the human papillomavirus (HPV) which is responsible for about 70 percent of cases of cervical cancer.

At a medical conference in Prague researchers who undertook a computer model study funded by GlaxoSmithKline predicted the impact the vaccine would have in Britain if all 12 year-old girls were vaccinated.

According to them if coverage was 100 percent, the company claimed that it could lead to a decrease in deaths by 76 percent. The research revealed that eighty percent vaccine coverage could reduce cases and deaths by 61 percent.

The researchers said, "Over the lifetime of a UK cohort of 12 year old females, the model predicts the occurrence of 2,636 cervical cancer cases and 1,403 cancer deaths without vaccination. With vaccination at 100 percent coverage, the forecast would be as low as 632 cancer cases (76 percent reduction) and 335 cancer deaths (also 76 percent reduction)."

These estimates have been made based on the vaccination being paired with the existing cervical screening program. Dr Anne Szarewski, of the charity Cancer Research UK, said HPV vaccination offers hope of reducing cases and preventing deaths from the illness.

She said, "Currently there are 3,000 women in the UK who get cervical cancer each year -- despite a highly efficient screening program."

Competing drug manufacturer Merck & Co Inc has also produced a vaccine to prevent cervical cancer. Their vaccine, Gardasil has been recommended by the European Medicines Agency to prevent cancer caused by four strains of HPV. The U.S. Food and Drug Administration in June has approved it.


NLA
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... ... ... “To Walk Away”: a captivating and romantic sequel to the romantic story of ... the creation of published author, Larry R. Sherman, a retired chemistry professor from the ... as well as four novels. , Though the book opens in 1947, when ...
(Date:8/22/2017)... Carolina (PRWEB) , ... August 22, 2017 , ... ... advisor. Mr. Stewart is the Founder and Managing Member for t4 Leadership Development ... have become critical to his definition of “success”: physician leadership development, servant leadership, ...
(Date:8/21/2017)... ... August 22, 2017 , ... Nanoparticle research provides an ... safety. By learning and implementing best practices for containment using ventilated safety enclosures, ... will gain a better understanding of a method for safely testing nanotechnology hoods. ...
(Date:8/21/2017)... ... August 21, 2017 , ... Five chefs from local senior assisted living ... Center. , Guests will be able to vote for their favorite Chef among ... with Fennel Dill Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice ...
(Date:8/21/2017)... ... ... The American Hospital Association (AHA) has elected Claire Zangerle, Chief Nurse Executive ... of Trustees for a three-year term beginning January 1, 2018. , The ... are committed to the improvement of health in their communities. Founded in 1898, the ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) today announced ... Aug. 7, 2017. ... and will serve as president emeritus during a planned, 90-day ... multiple leadership roles since he joined Diplomat with the acquisition ... decisive, strategic leadership which continues to benefit our patients and ...
(Date:8/7/2017)... 7, 2017  Endo International plc (NASDAQ: ... resolve virtually all known U.S. mesh product liability claims ... the known remaining U.S. claims at reasonable values. Under ... the fourth quarter of 2017 and continuing through the ... quarter 2017 results, the Company intends to increase its ...
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
Breaking Medicine Technology: